Full Text
Cost-Effectiveness of Pembrolizumab for The First-Line Treatment of Metastatic Non-Small Cell Lung Carcinoma in Portugal

Abstract

Authors

BA Pinheiro J Alarcão L Silva Miguel M Huang S Chandwani F Vargas Lopes M Borges

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×